google-site-verification: googlec7193c3de77668c9.html

Cracking prostate cancer's code: An enzyme's central role in controlling subtypes and improving therapeutic response

[
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at EPFL, and Eneda Toska at Johns Hopkins University have identified the enzyme KMT2D as a key epigenetic regulator in prostate cancer. Their study published in Cancer Research reveals that KMT2D plays a central role in shaping how prostate tumors grow, survive, and respond to therapy.


Source link

Advertisements
Views: 0

See also  Welsh rugby future uncertainty tough on players - Tomos Williams

Check Also

Sunshine to meal times: How to beat jet lag

With bags packed and boarding passes at the ready, what can you do to keep …

How home gardens can reduce risk of type 2 diabetes

[ People with home gardens are less likely to develop type 2 diabetes, a University …

Containment costs reveal when pandemic measures should shift from none to intensive

[ In the event of a pandemic, every society is confronted with the question: How …

Leave a Reply

Available for Amazon Prime
Elfbar elfa kit. elfbar elfx kit silver blue.